ViiV Healthcare announces FDA approval of the first complete long-acting regimen for HIV treatment
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics
Video explains the top 5 reasons why to switch from manual to automatic titration
QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
In this article, Thurid Gspann, chairwoman of the Graphene Flagship Standardization Committee (GFSC), explains why standardization is important
This system aims to combine Shimadzu gas chromatography with the patented technology jointly owned by TOTAL, UPPA, and UO
This aims to improve hygiene in public transportation and a reduction in transmission of infections of various origins
Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread
Accurate measurements of crystalline deformation should help engineer stronger components for more energy-efficient turbines
Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression